Pomalidomide re-exposure after drug-related severe hypothyroidism: a case report Consider testing thyroid function in patients receiving pomalidomide prior to and then every 2–3 months during treatment. If drug-induced hypothyroidism occurs, once the patient reaches a state of…

#MedCase - Consider testing thyroid function in patients receiving #pomalidomide prior to and then every 2–3 months during treatment. If drug-induced #hypothyroidism occurs, once the patient reaches a state of euthyroidism, rechallenge can be feasible.

👉 buff.ly/Oh4aqjM

#OncSky

Compared with #pomalidomide and #dexamethasone, #venetoclax and dexamethasone did not produce statistically different PFS in those with R/R t(11;14) multiple #myeloma #MMsm, an indication that the combo may not be a good option in this patient population: https://ow.ly/Z0Pf50YsTST
#HemeSky #MedSky

Breckenridge Pharmaceutical Expands Oncology Offerings with New Pomalidomide Capsules Breckenridge Pharmaceutical has officially launched Pomalidomide Capsules, enhancing its oncology portfolio with a cost-effective solution for patients with complex medical conditions.

Breckenridge Pharmaceutical Expands Oncology Offerings with New Pomalidomide Capsules #United_States #Berkeley_Heights #Breckenridge_Pharmaceutical #Pomalidomide #NATCO_Pharma

🩸Facts about Multiple Myeloma:

Treatment Sequencing and Combinations

#MultipleMyeloma #Hematology #MedEd #HEMEHUB #Daratumumab #BispecificAntibodies #Teclistamab #IMiDs #Lenalidomide #Pomalidomide #Carfilzomib #Immunotherapy #Oncology

🩸 Today’s question focuses on combination therapy evaluated in the MajesTEC-3 trial for relapsed/refractory multiple myeloma (RRMM).

See the answer and explanation on the next slide!

#MultipleMyeloma #Teclistamab #Pomalidomide #Daratumumab #Elranatamab #Carfilzomib #Talquetamab #Hematology

🩸🔬Today's question!

See the answer and explanation on the next slide.

#MultipleMyeloma #MAIATrial #FrontlineTherapy #Hematology #HemeOnc #ClinicalTrials #CancerTherapy #HEMEHUB #CyBorD #Daratumumab #Lenalidomide #Dexamethasone #DRd #Bortezomib #Thalidomide #Pomalidomide

Résultats #Majestec_3, le Dr Mateos a présenté le #LBA_6 : Étude randomisée de phase 3 du #Teclistamab plus #Daratumumab versus choix de l’investigateur entre dara et #Dexaméthasone avec #Pomalidomide ou #Bortézomib (#DPd/#DVd) chez des patients atteints de #MyélomeMultiple R/R

Subcutaneous Isatuximab Noninferior to IV Administration in R/R MM | ASH Clinical News | American Society of Hematology

Subcutaneous #isatuximab delivered via an on-body injector was found to be noninferior to IV isatuximab plus #pomalidomide and #dexamethasone in patients with R/R #MultipleMyeloma #MMsm, with both methods resulting in comparable ORR and 12-month PFS: ow.ly/zJCh50WM6cl
#HemeSky #MyelomaSky #HemeOnc

Mieloma multiplo, Cavo (UniBo): "Importanti nuove combinazioni approvate da Ue" (Adnkronos) - "L'approvazione in Europa delle combinazioni di belantamab mafodotin con bortezomib-desametasone (BVd) o pomalidomide-desametasone (BPd) per pazienti con mieloma multiplo ricaduto o refrattario, dopo almeno una precedente ...

È ACCADUTO IERI: Mieloma multiplo, Cavo (UniBo): "Importanti nuove combinazioni approvate da Ue" ... LEGGI TUTTO #MielomaMultiplo #BelantamabMafodotin #Bortezomib #Desametasone #Pomalidomide

Anticancéreux POMALIDOMIDE VIATRIS en boîte de 21 gélules : rappel général et consignes associées

🚨 URGENT 🚨
L' #ANSM rappelle tous les lots de #Pomalidomide 💊
Les 2 500 patients français qui prennent ce médicament pour traiter notamment un #MyélomeMultiple 🩸 sont donc invités à le ramener dans les pharmacies des hôpitaux où ils sont soignés.
www.vidal.fr/actualites/3...